Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Data is from peer-reviewed journal

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
Fragrance raw materials monographs: α-Santalol
Author:
Opdyke
Year:
1974
Bibliographic source:
Food and Cosmetics Toxicology, Volume 12, Issues 7–8, December 1974, Pages 991-992
Reference Type:
secondary source
Title:
Scientific Literature Review of Alicyclic Compounds of Carbon, Hydrogen and Oxygen in Flavor Usage
Author:
Flavor and Extract Manufacturers' Association
Year:
1985
Bibliographic source:
National Technical Information Service, Volume I, 1-648, 1985

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: as below
Principles of method if other than guideline:
Acute oral toxicity of α-Santalol in rats
GLP compliance:
not specified
Test type:
other: No data
Limit test:
no

Test material

Constituent 1
Reference substance name:
5-(2,3-dimethyltricyclo[2.2.1.02,6]hept-3-yl)-2-methylpent-2-en-1-ol, stereoisomer
EC Number:
204-102-8
EC Name:
5-(2,3-dimethyltricyclo[2.2.1.02,6]hept-3-yl)-2-methylpent-2-en-1-ol, stereoisomer
Cas Number:
115-71-9
IUPAC Name:
5-(2,3-dimethyltricyclo[2.2.1.0~2,6~]hept-3-yl)-2-methylpent-2-en-1-ol
Constituent 2
Reference substance name:
α-Santalol
IUPAC Name:
α-Santalol
Constituent 3
Reference substance name:
[1S-[1α,2α(Z),4α]]-2-methyl-5-(2-methyl-3-methylenebicyclo[2.2.1]hept-2-yl)-2-penten-1-ol
EC Number:
201-027-2
EC Name:
[1S-[1α,2α(Z),4α]]-2-methyl-5-(2-methyl-3-methylenebicyclo[2.2.1]hept-2-yl)-2-penten-1-ol
Cas Number:
77-42-9
IUPAC Name:
2-methyl-5-(2-methyl-3-methylenebicyclo[2.2.1]hept-2-yl)pent-2-en-1-ol
Test material form:
liquid: viscous
Details on test material:
- Name of test material (as cited in study report): α-Santalol
- Molecular formula (if other than submission substance): C15H24O
- Molecular weight (if other than submission substance): 220.3536 g/mole
- Substance type: Organic
- Physical state: Almost colorless, viscous liquid; sweet, woody odor (ARC)

Test animals

Species:
rat
Strain:
not specified
Sex:
not specified
Details on test animals or test system and environmental conditions:
No data available

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
not specified
Details on oral exposure:
No data available
Doses:
3800 mg/kg bw
No. of animals per sex per dose:
No data available
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 14 days
Statistics:
No data available

Results and discussion

Preliminary study:
No data available
Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
3 800 mg/kg bw
95% CL:
3 060 - 4 710
Remarks on result:
other: 50 % mortality observed
Mortality:
50 % mortality observed in treated male and female rats.
Clinical signs:
other: No data available
Gross pathology:
No data available
Other findings:
No data available

Applicant's summary and conclusion

Interpretation of results:
practically nontoxic
Conclusions:
LD50 was considered to be 3800 mg/kg bw (3060 – 4710 mg/kg bw ) when male and female rats were treated with α-Santalol orally.
Executive summary:

In a acute oral toxicity study,male and female rats were treated with α-Santalol in the concentration of3800 mg/kg bw orally and observed for 14 days. 50 % mortality observed in treated male and female rats. LD50 was considered to be 3800 mg/kg bw( 3060 – 4710 mg/kg bw) when male and female rats were treated with α-Santalol orally.